These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 30521942)

  • 41. Transcatheter embolic coils to treat peridevice leaks after left atrial appendage closure.
    Musikantow DR; Shivamurthy P; Croft LB; Kawamura I; Turagam MK; Whang W; Dukkipati SR; Goldman ME; Reddy VY
    Heart Rhythm; 2021 May; 18(5):717-722. PubMed ID: 33549807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left Atrial Appendage Closure in Patients With Intracranial Hemorrhage and Nonvalvular Atrial Fibrillation.
    Ajmal M; Naik H; Kocheril A
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104685. PubMed ID: 32057654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
    Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
    Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
    Reddy VY; Akehurst RL; Amorosi SL; Gavaghan MB; Hertz DS; Holmes DR
    Stroke; 2018 Jun; 49(6):1464-1470. PubMed ID: 29739915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
    Reddy VY; Doshi SK; Sievert H; Buchbinder M; Neuzil P; Huber K; Halperin JL; Holmes D;
    Circulation; 2013 Feb; 127(6):720-9. PubMed ID: 23325525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
    López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device.
    Kaneko H; Neuss M; Weissenborn J; Butter C
    Heart Vessels; 2017 Sep; 32(9):1137-1143. PubMed ID: 28477098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
    Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
    Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry.
    Hara H; Kubo S; Nakajima Y; Matsumoto T; Kondo Y; Sugane H; Okubo K; Nakagawa K; Nagatomo D; Hachinohe D; Kusa S; Goya M; Nanasato M; Arita T; Yamasaki H; Kuwabara K; Yoshiyama T; Tanaka N; Masuda M; Sakamoto T; Nakashima M; Ohno Y; Saito S; Fukunaga M
    J Cardiol; 2024 May; 83(5):298-305. PubMed ID: 37802202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracardiac Echocardiography to Guide Watchman FLX Implantation: The ICE LAA Study.
    Nielsen-Kudsk JE; Berti S; Caprioglio F; Ronco F; Arzamendi D; Betts T; Tondo C; Christen T; Allocco DJ
    JACC Cardiovasc Interv; 2023 Mar; 16(6):643-651. PubMed ID: 36764917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation.
    Panikker S; Lord J; Jarman JW; Armstrong S; Jones DG; Haldar S; Butcher C; Khan H; Mantziari L; Nicol E; Hussain W; Clague JR; Foran JP; Markides V; Wong T
    Eur Heart J; 2016 Dec; 37(46):3470-3482. PubMed ID: 26935273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left atrial appendage closure in patients with intracranial haemorrhage and atrial fibrillation.
    Fayos-Vidal F; Arzamendi-Aizpurua D; Millán-Álvarez X; Guisado-Alonso D; Camps-Renom P; Prats-Sánchez L; Martínez-Domeño A; Delgado-Mederos R; Martí-Fàbregas J
    Neurologia (Engl Ed); 2020; 35(1):10-15. PubMed ID: 28865942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device.
    Fu G; Wang B; He B; Yu Y; Wang Z; Feng M; Liu J; Du X; Zhuo W; Chu H
    J Formos Med Assoc; 2022 Aug; 121(8):1488-1494. PubMed ID: 34740490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.
    Calvo N; Salterain N; Arguedas H; Macias A; Esteban A; García de Yébenes M; Gavira JJ; Barba J; García-Bolao I
    Europace; 2015 Oct; 17(10):1533-40. PubMed ID: 25935163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Left Atrial Appendage Closure With WATCHMAN in Japanese Nonvalvular Atrial Fibrillation Patients　- Final 2-Year Follow-up Outcome Data From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Matsumoto T; Takayama M; Ando K; Hirao K; Goya M; Morino Y; Hayashida K; Kusano K; Gomi Y; Main ML; Uchida T; Saito S
    Circ J; 2020 Jul; 84(8):1237-1243. PubMed ID: 32595176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.
    Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K
    Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial.
    Wazni OM; Boersma L; Healey JS; Mansour M; Tondo C; Phillips K; Doshi R; Jaber W; Hynes E; Allocco DJ; Reddy VY
    Am Heart J; 2022 Sep; 251():35-42. PubMed ID: 35526570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.